Glutaredoxin 2 reduces both thioredoxin 2 and thioredoxin 1 and protects cells from apoptosis induced by auranofin and 4-Hydroxynonenal

Antioxidants and Redox Signaling

Volumn 21, Issue 5, 2014, Pages 669-681

  Zhang, Huihui ^a   Du, Yatao ^a   Zhang, Xu ^a   Lu, Jun ^a   Holmgren, Arne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; AURANOFIN; GLUTAREDOXIN 2; GLUTATHIONE; OXIDOREDUCTASE; REDUCING AGENT; THIOREDOXIN 1; THIOREDOXIN 2; UNCLASSIFIED DRUG; 4-HYDROXY-2-NONENAL; ALDEHYDE; GLRX2 PROTEIN, HUMAN; GLUTAREDOXIN; MITOCHONDRIAL PROTEIN; THIOREDOXIN; THIOREDOXIN REDUCTASE; TXN2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL PROTECTION; FEMALE; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MITOCHONDRION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION; STRUCTURE ACTIVITY RELATION;

ALDEHYDES; APOPTOSIS; AURANOFIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAREDOXINS; HELA CELLS; HUMANS; MITOCHONDRIAL PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; STRUCTURE-ACTIVITY RELATIONSHIP; THIOREDOXIN-DISULFIDE REDUCTASE; THIOREDOXINS;

EID: 84902294371     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5499     Document Type: Article

References (45)

1. Abarikwu SO, Pant AB, and Farombi EO. 4-Hydroxynonenal induces mitochondrial-mediated apoptosis and oxidative stress in SH-SY5Y human neuronal cells. Basic Clin Pharmacol Toxicol 110: 441-448, 2012.
2. Anathy V, Roberson EC, Guala AS, Godburn KE, Budd RC, and Janssen-Heininger YM. Redox-based regulation of apoptosis: S-glutathionylation as a regulatory mechanism to control cell death. Antioxid Redox Signal 16: 496-505, 2012.
3. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, and Murphy MP. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 279: 47939-47951, 2004.
4. Berndt C, Hudemann C, Hanschmann EM, Axelsson R, Holmgren A, and Lillig CH. How does iron-sulfur cluster coordination regulate the activity of human glutaredoxin 2? Antioxid Redox Signal 9: 151-157, 2007.
5. Berndt C, Lillig CH, and Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 292: H1227-H1236, 2007.
6. Berndt C, Lillig CH, and Holmgren A. Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim Biophys Acta 1783: 641-650, 2008.
7. Bersani NA, Merwin JR, Lopez NI, Pearson GD, and Merrill GF. Protein electrophoretic mobility shift assay to monitor redox state of thioredoxin in cells. Methods Enzymol 347: 317-326, 2002.
8. Circu ML and Aw TY. Glutathione and modulation of cell apoptosis. Biochim Biophys Acta 1823: 1767-1777, 2012.
9. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, Beck H, Hatzopoulos AK, Just U, Sinowatz F, Schmahl W, Chien KR, Wurst W, Bornkamm GW, and Brielmeier M. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24: 9414-9423, 2004.
10. Di Sarra F, Fresch B, Bini R, Saielli G, and Bagno A. Reactivity of auranofin with selenols and thiols-implications for the anticancer activity of gold(I) compounds. Eur J Inorg Chem 2013: 2718-2727, 2013.
11. Du Y, Zhang H, Lu J, and Holmgren A. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. J Biol Chem 287: 38210-38219, 2012.
12. Enoksson M, Fernandes AP, Prast S, Lillig CH, Holmgren A, and Orrenius S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun 327: 774-779, 2005.
13. Fang J and Holmgren A. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc 128: 1879-1885, 2006.
14. Ferri A, Fiorenzo P, Nencini M, Cozzolino M, Pesaresi MG, Valle C, Sepe S, Moreno S, and Carri MT. Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity. Hum Mol Genet 19: 4529-4542, 2010.
15. Gustafsson TN, Sahlin M, Lu J, Sjoberg BM, and Holmgren A. Bacillus anthracis thioredoxin systems, characterization and role as electron donors for ribonucleotide reductase. J Biol Chem 287: 39686-39697, 2012.
16. Hashemy SI and Holmgren A. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 283: 21890-21898, 2008.
17. Hashemy SI, Johansson C, Berndt C, Lillig CH, and Holmgren A. Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity. J Biol Chem 282: 14428-14436, 2007.
18. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638, 1997.
19. Holmgren A, Johansson C, Berndt C, Lonn ME, Hudemann C, and Lillig CH. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans 33: 1375-1377, 2005.
20. Johansson C, Lillig CH, and Holmgren A. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem 279: 7537-7543, 2004.
21. Kanzok SM, Schirmer RH, Turbachova I, Iozef R, and Becker K. The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J Biol Chem 275: 40180-40186, 2000.
22. Lee SR, Kim JR, Kwon KS, Yoon HW, Levine RL, Ginsburg A, and Rhee SG. Molecular cloning and characterization of a mitochondrial selenocysteine- containing thioredoxin reductase from rat liver. J Biol Chem 274: 4722-4734, 1999.
23. Lillig CH, Berndt C, and Holmgren A. Glutaredoxin systems. Biochim Biophys Acta 1780: 1304-1317, 2008.
24. Lillig CH, Berndt C, Vergnolle O, Lonn ME, Hudemann C, Bill E, and Holmgren A. Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor. Proc Natl Acad Sci U S A 102: 8168-8173, 2005.
25. Lillig CH and Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxid Redox Signal 9: 25-47, 2007.
26. Lillig CH, Lonn ME, Enoksson M, Fernandes AP, and Holmgren A. Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc Natl Acad Sci U S A 101: 13227-13232, 2004.
27. Lonn ME, Hudemann C, Berndt C, Cherkasov V, Capani F, Holmgren A, and Lillig CH. Expression pattern of human glutaredoxin 2 isoforms: identification and characterization of two testis/cancer cell-specific isoforms. Antioxid Redox Signal 10: 547-557, 2008.
28. Lundberg M, Johansson C, Chandra J, Enoksson M, Jacobsson G, Ljung J, Johansson M, and Holmgren A. Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem 276: 26269-26275, 2001.
29. Mari M, Morales A, Colell A, Garcia-Ruiz C, and Fernandez-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11: 2685-2700, 2009.
30. Mari M, Morales A, Colell A, Garcia-Ruiz C, Kaplowitz N, and Fernandez-Checa JC. Mitochondrial glutathione: features, regulation and role in disease. Biochim Biophys Acta 1830: 3317-3328, 2013.
31. Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, and Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 178: 179-185, 1996.
32. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, and Hay RT. Thioredoxin regulates the DNA binding activity of NFkappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20: 3821-3830, 1992.
33. Meuillet EJ, Mahadevan D, Berggren M, Coon A, and Powis G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys 429: 123-133, 2004.
34. Nonn L, Williams RR, Erickson RP, and Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003.
35. Rackham O, Shearwood AM, Thyer R, McNamara E, Davies SM, Callus BA, Miranda-Vizuete A, Berners-Price SJ, Cheng Q, Arner ES, and Filipovska A. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors. Free Radic Biol Med 50: 689-699, 2011.
36. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.
37. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
38. Spyrou G, Enmark E, Miranda-Vizuete A, and Gustafsson J. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 272: 2936-2941, 1997.
39. Stanley BA, Sivakumaran V, Shi S, McDonald I, Lloyd D, Watson WH, Aon MA, and Paolocci N. Thioredoxin reductase-2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria. J Biol Chem 286: 33669-33677, 2011.
40. Takahashi N and Hirose M. Determination of sulfhydryl groups and disulfide bonds in a protein by polyacrylamide gel electrophoresis. Anal Biochem 188: 359-365, 1990.
41. Ungerstedt J, Du Y, Zhang H, Nair D, and Holmgren A. In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). Free Radic Biol Med 53: 2002-2007, 2012.
42. Wu H, Xing K, and Lou MF. Glutaredoxin 2 prevents H2O2-induced cell apoptosis by protecting complex I activity in the mitochondria. Biochim Biophys Acta 1797: 1705-1715, 2010.
43. Yan MH, Wang X, and Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med 62: 90-101, 2013.
44. Zhang H, Cao D, Cui W, Ji M, Qian X, and Zhong L. Molecular bases of thioredoxin and thioredoxin reductasemediated prooxidant actions of (-)-epigallocatechin-3-gallate. Free Radic Biol Med 49: 2010-2018, 2010.
45. Zhang H, Go YM, and Jones DP. Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys 465: 119-126, 2007.